FORBES-TATE

Lobbying for GRAIL, INC. · Biotechnology Company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $50,000.00 income · posted Jan 18, 2026

Lobbying activity 2

Health Issues

Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.

Medicare/Medicaid

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.